Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.
2.

Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.

Jaikaran ET, Clark A.

Biochim Biophys Acta. 2001 Nov 29;1537(3):179-203. Review.

3.

Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.

Jeong HR, An SS.

Clin Interv Aging. 2015 Nov 19;10:1873-9. doi: 10.2147/CIA.S95297. eCollection 2015. Review.

4.

Islet amyloid polypeptide and type 2 diabetes.

Marzban L, Park K, Verchere CB.

Exp Gerontol. 2003 Apr;38(4):347-51. Review.

PMID:
12670620
5.

Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Westermark P, Andersson A, Westermark GT.

Physiol Rev. 2011 Jul;91(3):795-826. doi: 10.1152/physrev.00042.2009. Review.

6.

[Construction of transgenic mouse system expressing human islet amyloid polypeptide (IAPP)/amylin].

Yagui K, Kanatsuka A, Makino H.

Nihon Rinsho. 1994 Oct;52(10):2746-50. Review. Japanese.

PMID:
7983808
7.

Islet amyloid in type 2 (non-insulin-dependent) diabetes.

Clark A, Chargé SB, Badman MK, de Koning EJ.

APMIS. 1996 Jan;104(1):12-8. Review.

PMID:
8645452
8.

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn SE, Andrikopoulos S, Verchere CB.

Diabetes. 1999 Feb;48(2):241-53. Review.

PMID:
10334297
9.

Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis.

Nguyen PT, Andraka N, De Carufel CA, Bourgault S.

J Diabetes Res. 2015;2015:515307. doi: 10.1155/2015/515307. Epub 2015 Oct 20. Review.

10.

Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice.

Höppener JW, Oosterwijk C, van Hulst KL, Verbeek JS, Capel PJ, de Koning EJ, Clark A, Jansz HS, Lips CJ.

J Cell Biochem. 1994;55 Suppl:39-53. Review.

PMID:
7929617
11.

Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).

Westermark P.

Diabet Med. 1996 Sep;13(9 Suppl 6):S46-8. Review.

PMID:
8894481
12.

Membrane permeabilization by Islet Amyloid Polypeptide.

Engel MF.

Chem Phys Lipids. 2009 Jul;160(1):1-10. doi: 10.1016/j.chemphyslip.2009.03.008. Epub 2009 Apr 7. Review.

PMID:
19501206
13.

[Role of IAPP in the pathogenesis and development of NIDDM].

Sanke T, Nishi M, Nanjo K.

Nihon Rinsho. 1994 Oct;52(10):2737-45. Review. Japanese.

PMID:
7983807
14.

Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Cao P, Marek P, Noor H, Patsalo V, Tu LH, Wang H, Abedini A, Raleigh DP.

FEBS Lett. 2013 Apr 17;587(8):1106-18. doi: 10.1016/j.febslet.2013.01.046. Epub 2013 Feb 1. Review.

15.

Membrane interaction of islet amyloid polypeptide.

Jayasinghe SA, Langen R.

Biochim Biophys Acta. 2007 Aug;1768(8):2002-9. Epub 2007 Feb 6. Review.

16.

Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology.

Cao P, Abedini A, Raleigh DP.

Curr Opin Struct Biol. 2013 Feb;23(1):82-9. doi: 10.1016/j.sbi.2012.11.003. Epub 2012 Dec 22. Review.

17.

Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?

Westermark P, Andersson A, Westermark GT.

Curr Diab Rep. 2005 Jun;5(3):184-8. Review.

PMID:
15929864
18.

Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Abedini A, Schmidt AM.

FEBS Lett. 2013 Apr 17;587(8):1119-27. doi: 10.1016/j.febslet.2013.01.017. Epub 2013 Jan 18. Review.

19.

Misfolded proteins in Alzheimer's disease and type II diabetes.

DeToma AS, Salamekh S, Ramamoorthy A, Lim MH.

Chem Soc Rev. 2012 Jan 21;41(2):608-21. doi: 10.1039/c1cs15112f. Epub 2011 Aug 4. Review.

20.

Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives.

Pithadia A, Brender JR, Fierke CA, Ramamoorthy A.

J Diabetes Res. 2016;2016:2046327. doi: 10.1155/2016/2046327. Epub 2015 Nov 15. Review.

Supplemental Content

Support Center